biospecimen__admin__batch_number	345.53.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	9B49612C-4564-4F5F-9C05-70D90F660E92
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-A7M5-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-A7M5-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-A7M5-01A
biospecimen__bio__biospecimen_barcode_bottom	0160356547
biospecimen__bio__day_of_creation	01
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	10
biospecimen__bio__month_of_shipment	10
biospecimen__bio__pathology_report_file_name	TCGA-G3-A7M5.9441C376-F0CE-4A84-A9C0-5FB1917216F2.pdf
biospecimen__bio__plate_column	5
biospecimen__bio__plate_id	A343
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-G3-A7M5
biospecimen__shared__patient_id	A7M5
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	39B50554-14BC-4188-86D7-F778E360B230
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.3
clinical__chol_lihc_shared__albumin_result_specified_value	4.1
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	6
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	76
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-A7M5-F65810
clinical__clin_shared__bcr_followup_uuid	630910C8-FFF6-433D-BD1A-F68F7400FC7C
clinical__clin_shared__day_of_form_completion	5
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	2
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	181
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	76fce556-8d25-4713-a725-7041107e0141
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-A7M5-01A-11R-A343-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	d67341d4-212d-4e66-ad3f-0cb95d0f2eac
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	7c02aec5-e47c-4edf-a25d-49ebe4ffacd1
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	869f8a17-bced-4002-bd60-99df84a03b93
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:34:57.516354-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	85f253fc-0bd9-54de-85e4-ed3cf4a8d075
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1937
gdc__diagnoses__age_at_diagnosis	27963
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-27963.0
gdc__diagnoses__days_to_last_follow_up	447.0
gdc__diagnoses__diagnosis_id	e429a666-3777-52b6-99e9-dcf40d5da392
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	25.28256989886972
gdc__exposures__exposure_id	9a6a51ea-bac5-50a5-a29c-b77f8ffe63b1
gdc__exposures__height	164.0
gdc__exposures__weight	68.0
gdc__file_id	7b947fea-50ed-4e40-8e32-a8f8ce6a1cc4
gdc__file_name	d56eae47-6e27-4938-92dd-e3b5c69d2480.mirbase21.mirnas.quantification.txt
gdc__file_size	50181
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	e924034eda3220812304e2b7c15d1f8d
gdc__portions__is_ffpe	false
gdc__portions__portion_id	d36dc372-6851-4452-8bc8-ef1e42ddac4c
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	217
gdc__samples__initial_weight	720.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	9441C376-F0CE-4A84-A9C0-5FB1917216F2
gdc__samples__sample_id	738d9234-646f-431b-8ee3-661d2b3ca23b
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	1.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	2.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	13.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	52e13dad-b681-4aa7-b20c-a3d3d206b7ff
gdc__submitter_id	mirna_swap_dr11_183_MirnaExpression65a30298-eff6-4ef7-96f8-708794c8ef28_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	b5083b7e-110d-5bf0-846c-e008d2dc55b6
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:26.848+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/76fce556-8d25-4713-a725-7041107e0141-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/76fce556-8d25-4713-a725-7041107e0141-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129552
manually_curated__local_md5	0ec6933e359388642967fdeb6de29572
manually_curated__opengdc_download_date	2018-10-16T17:10:10.000594+02:00
manually_curated__opengdc_file_md5	8788a4bac62dfd99ecaf8496c12a774b
manually_curated__opengdc_file_size	50180
manually_curated__opengdc_id	76fce556-8d25-4713-a725-7041107e0141-meq
manually_curated__origin_file_size	129552
manually_curated__origin_last_modified_date	Tue Oct 16 17:43:00 CEST 2018
manually_curated__origin_md5	0ec6933e359388642967fdeb6de29572
manually_curated__tissue_status	tumoral
